{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:43:41Z","timestamp":1781577821785,"version":"3.54.5"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ivantis, Inc."},{"name":"Ivantis, Inc."},{"name":"Glaukos Corp"},{"name":"Alcon Laboratories, Inc."},{"name":"Transcend Medical, Inc."},{"name":"Ivantis, Inc."},{"name":"Alcon Laboratory, Inc."},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ivantis, Inc."},{"name":"Ivantis, Inc."}],"content-domain":{"domain":["jcrsjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jcrs.2019.03.024","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T21:38:54Z","timestamp":1563399534000},"page":"1305-1315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma"],"prefix":"10.1097","volume":"45","author":[{"given":"Jason","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas D.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Samuelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210210","doi-asserted-by":"crossref","first-page":"ORSF5","DOI":"10.1167\/iovs.13-12789","article-title":"The prevalence of age-related eye disease and visual impairment in aging: current estimates.","volume":"54","author":"Klein","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R2-15-20210210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/09286586.2012.698692","article-title":"Cataract surgery among Medicare beneficiaries.","volume":"19","author":"Schein","year":"2012","journal-title":"Ophthalmic Epidemiol"},{"key":"R3-15-20210210","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2013.05.027","article-title":"Lifetime risk of blindness in open-angle glaucoma.","volume":"156","author":"Peters","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R4-15-20210210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"R5-15-20210210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ophtha.2015.10.053","article-title":"Primary Open-Angle Glaucoma. Preferred Practice Pattern.","volume":"123","year":"2016","journal-title":"Ophthalmology"},{"key":"R6-15-20210210","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ophtha.2016.06.032","article-title":", for the CyPass Study Group. Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts.","volume":"123","author":"Vold","year":"2016","journal-title":"Ophthalmology"},{"key":"R7-15-20210210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ophtha.2018.05.012","article-title":", for the HORIZON Investigators. A Schlemms canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract; the HORIZON Study.","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"key":"R11-15-20210210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archopht.117.5.573","article-title":", for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study; design and baseline description of the participants.","volume":"117","author":"Gordon","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R12-15-20210210","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":", for the Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression; results from the Early Manifest Glaucoma Trial.","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R13-15-20210210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ophtha.2010.07.007","article-title":", for the US iStent Study Group. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract.","volume":"118","author":"Samuelson","year":"2011","journal-title":"Ophthalmology"},{"key":"R14-15-20210210","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jcrs.2012.03.025","article-title":", for the iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow up.","volume":"38","author":"Craven","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"R15-15-20210210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00061198-200310000-00001","article-title":"Compliance barriers in glaucoma: a systematic classification.","volume":"12","author":"Tsai","year":"2003","journal-title":"J Glaucoma"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335019302524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335019302524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2019.03.024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:36:52Z","timestamp":1623782212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2019.03.024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2019.03.024","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Cataract & Refractive Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrs.2019.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of ASCRS and ESCRS.","name":"copyright","label":"Copyright"}]}}